Recent insights in the mode of action of both GIPR and GLP1R agonism suggest involvement in (postprandial) lipid handling and inflammation as well,6,13,19 which may also impact NAFLD development. Here, GLP1R is linked to metabolic dysfunction-associated steatotic liver disease.